Technology
100 Most Popular
Most Popular Under $25

Vaxart

79,145

$7.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.63 (-7.87%) Today
+$0.07 (+0.95%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Vaxart and other stocks, options, ETFs, and crypto commission-free!

About VXRT

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. Read More The company was founded in 2004 and is headquartered in South San Francisco, CA.

CEO
Andrei Floroiu
Employees
14
Headquarters
South San Francisco, California
Founded
2004
Market Cap
546.74M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
61.85M
High Today
$8.15
Low Today
$7.10
Open Price
$8.07
Volume
17.87M
52 Week High
$14.30
52 Week Low
$0.2543

Collections

Technology
100 Most Popular
Most Popular Under $25
Health
Biotechnology
Medical

VXRT News

ReutersJun 26

Vaxart says potential COVID-19 vaccine picked for 'Operation Warp Speed'

(Reuters) - Vaxart Inc said on Friday it would test its experimental oral COVID-19 vaccine on monkeys infected with the new coronavirus in a study funded by the
0
BenzingaJun 26

Mid-Day Market Update: Crude Oil Down 2%; Vaxart Shares Spike Higher

Midway through trading Friday, the Dow traded down 2.01% to 25227.54 while the NASDAQ fell 1.45% to 9872.13. The S&P also fell, dropping 1.61% to 3,034.01. The
0

VXRT Earnings

-$0.69
-$0.46
-$0.23
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Aug 6, After Hours

You May Also Like

MAN
SPMV
GHG
BSMR
DOCU
FCAN
EGLE
BPMC
URTY
BRPAW
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy VXRT

Market Price$7.44
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Vaxart stock and options commission-free.
LearnBlogCareersHelpLog InSign Up